Like
Comment
Share
Drag to reposition cover
https://www.selleckchem.com/products/azd3965.html
CaV1.2 channel blockers or 5-HT2 receptor antagonists constitute effective therapy for Raynaud's syndrome. A functional link between the inhibition of 5-HT2 receptors and CaV1.2 channel blockade in arterial smooth muscles has been hypothesized. Therefore, the effects of ritanserin, a nonselective 5-HT2 receptor antagonist, on vascular CaV1.2 channels were investigated through electrophysiological, functional, and computational studies. Ritanserin blocked CaV1.2 channel currents (ICa1.2) in a concentration-dependent manner (Kr = 3.61 µM)
Like
Comment
Share
Load more posts
About
Brighten your smile with Sharing Smiles Dental Care! ?✨ We offer expert care with a gentle touch for healthy, confident smiles. Visit us or call now to book your appointment at +14165007250
Likes
(14)
Crop your avatar